Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
Clinical trial NCT05805007 · UNKNOWN
Trial details
- NCT number
- NCT05805007
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-12
- Primary completion
- 2026-04-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.